Vycor Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vycor Medical generated cash of $29,430, which is more than the previous year. Cash used in financing activities reached the amount of $211 last year. Net change in cash is therefore $20,256.
Cash Flow
| 2014 | -2.70M | -171.14K | 4.72M |
|---|---|---|---|
| 2015 | -1.16M | -294.30K | -85.3K |
| 2016 | -496.91K | -57.45K | 266.71K |
| 2017 | -527.43K | -183.25K | 863.85K |
| 2018 | -260.32K | -63.52K | 200.42K |
| 2019 | 7.22K | -58.25K | 40.09K |
| 2020 | -248.79K | -52.47K | 286.55K |
| 2021 | 21.36K | -38.37K | 61.94K |
| 2022 | -217.01K | -2.78K | 165.88K |
| 2023 | 29.43K | -9.38K | 211 |
VYCO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 37.03K | 90.94K | 46.00K | 60.71K | 86.48K | 206.21K | 56.85K | 347.47K | 1.89M | 31.30K |
Operating activities | ||||||||||
Net income | -69.69K | -404.91K | -435.66K | -822.48K | -796.20K | -1.37M | -1.47M | -1.65M | -2.08M | -4.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 60.75K | 61.40K | 68.41K | 57.89K | 69.43K | 177.35K | 289.97K | 267.49K | 368.96K | 382.98K |
Stock-based compensation expense | 10.14K | 185.61K | 341.09K | 520K | 534.94K | 0 | 334.97K | 482.11K | 274.50K | 376.66K |
| Deferred income tax benefit | 10.14K | 185.61K | 341.09K | 520K | 534.94K | 0 | 334.97K | 482.11K | 274.50K | 376.66K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -59.02K | -30.10K | 33.14K | 115.31K | -20.55K | -147.04K | 38.36K | -42.44K | 17.47K | 88.84K |
Inventories | 14.72K | -56.86K | -38.78K | 14.69K | -19.96K | 4.48K | -54.57K | 78.29K | 10.04K | -131.66K |
Accounts payable | -82.24K | -27.67K | 48.61K | -66.30K | 158.97K | -48.36K | -108.63K | -418 | 28.66K | -32.32K |
Cash generated by operating activities | 29.43K | -217.01K | 21.36K | -248.79K | 7.22K | -260.32K | -527.43K | -496.91K | -1.16M | -2.70M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -9.38K | -2.78K | -38.37K | -62.05K | -58.25K | -63.52K | -183.25K | -57.45K | -294.30K | -171.14K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -9.38K | -2.78K | -38.37K | -52.47K | -58.25K | -63.52K | -183.25K | -57.45K | -294.30K | -171.14K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 225K | 842.87K | 0 | 0 | 5M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -167.77K | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 211 | 0 | -6.65K | -2.04K | 40.09K | -200.42K | 1.53K | 0 | -85.3K | -357.85K |
Cash used in financing activities | 211 | 165.88K | 61.94K | 286.55K | 40.09K | 200.42K | 863.85K | 266.71K | -85.3K | 4.72M |
Net Change In Cash | 20.25K | -53.90K | 44.93K | -14.71K | -14.24K | -119.73K | 149.35K | -290.61K | -1.54M | 1.86M |
Cash at end of period | 57.29K | 37.03K | 90.94K | 46.00K | 72.23K | 86.48K | 206.21K | 56.85K | 347.47K | 1.89M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |